Wegovy pill, the first FDA‑approved oral GLP‑1 for weight loss, is now available via WeightWatchers Med+ from $149 per month for a limited time. Markets Insider: Weight Watchers Launches Eli Lilly and Company’s New Oral GLP-1 Foundayo® Available Through LillyDirect WW International, Inc. (NASDAQ: WW) (“Weight Watchers”), the global leader in science-backed weight management, announced that it is now offering access to Eli Lilly and Company’s newly FDA-approved ...

Understanding the Context

Weight Watchers Launches Eli Lilly and Company’s New Oral GLP-1 Foundayo® Available Through LillyDirect WW International (NASDAQ:WW), the global weight management company formerly known as Weight Watchers, released its fourth quarter and full-year 2025 financial results, showing stronger-than-expected ... Mena FN: Weight Watchers Announces Best In Market Self-Pay Wegovy® Pricing For Med+ Members And The Launch Of Preferred Subscription Pricing For Wegovy Via Novocare® Weight Watchers Announces Best In Market Self-Pay Wegovy® Pricing For Med+ Members And The Launch Of Preferred Subscription Pricing For Wegovy Via Novocare® New York Post: Weight Watchers made the new Wegovy pill actually affordable FinanzNachrichten.de: WW International Inc.: Weight Watchers Launches Eli Lilly and Company's New Oral GLP-1 Foundayo Available Through LillyDirect WW International, Inc. (NASDAQ: WW) ("Weight Watchers"), the global leader in science-backed weight management, announced that it is now offering access to ... WW International Inc.: Weight Watchers Launches Eli Lilly and Company's New Oral GLP-1 Foundayo Available Through LillyDirect